![American brands / Pharmacy / Specialty drugs / Biotechnology / Allergan / Plc / Hospira / Pfizer / WuXi PharmaTech / Biopharmaceutical / AstraZeneca / Infliximab / Teva Pharmaceutical Industries American brands / Pharmacy / Specialty drugs / Biotechnology / Allergan / Plc / Hospira / Pfizer / WuXi PharmaTech / Biopharmaceutical / AstraZeneca / Infliximab / Teva Pharmaceutical Industries](https://www.pdfsearch.io/img/1c661459a0ef8c82b3103e0bd6f1823c.jpg) Date: 2016-04-08 15:57:35American brands Pharmacy Specialty drugs Biotechnology Allergan Plc Hospira Pfizer WuXi PharmaTech Biopharmaceutical AstraZeneca Infliximab Teva Pharmaceutical Industries | | April 8, Pfizer and Allergan Terminate $160 Billion Merger; New US Treasury Department Action at Play Pfizer and Allergan have called off their proposed $160 billion merger citing the US DepartAdd to Reading ListSource URL: www.dcat.orgDownload Document from Source Website File Size: 297,81 KBShare Document on Facebook
|